UNIVERSAL PHARMA: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
UNIVERSAL PHARMA
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€2.0m
2024 · €1.9m+€180,396
Equity
€23.1m
2024 · €21.3m+€1.8m
Cash
€5.2m
2024 · €4.0m+€1.1m
Balance sheet total
€31.5m
2024 · €29.0m+€2.6m
Largest movements
Assets
- Cash +€1.1m
up €1.1m (+28.3%), from €4.0m to €5.2m
mainly Net result for the year (+€2.0m) and Depreciation (+€773,570)
- Financial fixed assets +€596,147
up €596,147 (+5.7%), from €10.4m to €11.0m
of which Affiliated companies: +€596,147
- Stocks and contracts +€413,598
up €413,598 (+9.8%), from €4.2m to €4.6m
Equity and liabilities
- Profit (loss) carried forward +€1.8m
up €1.8m (+12.8%), from €14.0m to €15.8m
- Trade debts +€494,113
up €494,113 (+17.3%), from €2.9m to €3.3m
of which Suppliers: +€468,627
- Debts after one year +€447,558
up €447,558 (+19.0%), from €2.3m to €2.8m
Income statement
- Turnover +€2.9m
up €2.9m (+5.9%), from €48.7m to €51.5m
- Goods and materials +€1.7m
up €1.7m (+5.3%), from €31.8m to €33.5m
of which Purchases: +€1.4m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€1.9m
Turnover
+€2.9m
Other operating income
+€43,602
Goods and materials
-€1.7m
Services and other goods
-€373,206
Staff costs
-€324,647
Depreciation
-€92,906
Write-downs
-€49,411
Provisions
+€31,100
Other operating charges
-€165,726
Other operating items
+€10,011
Financial income
-€11,679
Financial charges
+€7,252
Taxes
-€68,209
Result 2025
€2.0m
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
+€2.4m
Investment
-€1.5m
Financing
+€303,575
Cash 2024
€4.0m
From operations (derived)
+€2.4m
Net result for the year
+€2.0m
Depreciation
+€773,570
Stocks and contracts
-€413,598
Receivables within one year
-€230,005
Deferred charges and accrued income
-€29,586
Trade debts
+€494,113
Tax, wage and social debts
+€68,647
Other debts
-€219,746
Accrued charges and deferred income
-€126,345
Investment (derived)
-€1.5m
Investment in fixed assets (net)
-€1.5m
Financing
+€303,575
Debts after one year
+€447,558
Current portion of long-term debt
+€106,017
Contributions, distributions and other
-€250,000
Cash 2025
€5.2m
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €28,969,163 | €31,525,886 | +€2.6m | +8.8% |
| Fixed assets | 21/28 | €15,598,348 | €16,341,701 | +€743,353 | +4.8% |
| Intangible fixed assets | 21 | €60,801 | €31,195 | -€29,606 | -48.7% |
| Tangible fixed assets | 22/27 | €5,120,970 | €5,297,782 | +€176,812 | +3.5% |
| Land and buildings | 22 | €3,039,031 | €2,956,048 | -€82,983 | -2.7% |
| Plant, machinery and equipment | 23 | €502,771 | €427,393 | -€75,378 | -15.0% |
| Furniture and vehicles | 24 | €383,434 | €462,509 | +€79,075 | +20.6% |
| Other tangible fixed assets | 26 | €1,195,734 | €1,451,832 | +€256,098 | +21.4% |
| Financial fixed assets | 28 | €10,416,577 | €11,012,724 | +€596,147 | +5.7% |
| Affiliated companies | 280/1 | €10,415,800 | €11,011,947 | +€596,147 | +5.7% |
| Participating interests | 280 | €10,415,800 | €11,011,947 | +€596,147 | +5.7% |
| Other financial fixed assets | 284/8 | €777 | €777 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €777 | €777 | = | 0.0% |
| Current assets | 29/58 | €13,370,815 | €15,184,185 | +€1.8m | +13.6% |
| Stocks and contracts in progress | 3 | €4,230,531 | €4,644,129 | +€413,598 | +9.8% |
| Stocks | 30/36 | €4,230,531 | €4,644,129 | +€413,598 | +9.8% |
| Goods purchased for resale | 34 | €4,230,531 | €4,644,129 | +€413,598 | +9.8% |
| Amounts receivable within one year | 40/41 | €5,077,461 | €5,307,466 | +€230,005 | +4.5% |
| Trade receivables | 40 | €4,725,214 | €4,261,033 | -€464,181 | -9.8% |
| Other amounts receivable | 41 | €352,247 | €1,046,433 | +€694,186 | +197.1% |
| Cash at bank and in hand | 54/58 | €4,035,614 | €5,175,795 | +€1.1m | +28.3% |
| Deferred charges and accrued income | 490/1 | €27,209 | €56,795 | +€29,586 | +108.7% |
| Total equity and liabilities | 10/49 | €28,969,163 | €31,525,886 | +€2.6m | +8.8% |
| Equity | 10/15 | €21,266,093 | €23,052,572 | +€1.8m | +8.4% |
| Contributions | 10/11 | €1,500,000 | €1,500,000 | = | 0.0% |
| Capital | 10 | €1,500,000 | €1,500,000 | = | 0.0% |
| Issued capital | 100 | €1,500,000 | €1,500,000 | = | 0.0% |
| Reserves | 13 | €5,800,000 | €5,800,000 | = | 0.0% |
| Non-distributable reserves | 130/1 | €150,000 | €150,000 | = | 0.0% |
| Legal reserve | 130 | €150,000 | €150,000 | = | 0.0% |
| Distributable reserves | 133 | €5,650,000 | €5,650,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €13,966,093 | €15,752,572 | +€1.8m | +12.8% |
| Provisions and deferred taxes | 16 | €31,100 | €31,100 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €31,100 | €31,100 | = | 0.0% |
| Other liabilities and charges | 164/5 | €31,100 | €31,100 | = | 0.0% |
| Amounts payable | 17/49 | €7,671,970 | €8,442,214 | +€770,244 | +10.0% |
| Amounts payable after more than one year | 17 | €2,349,422 | €2,796,980 | +€447,558 | +19.0% |
| Financial debts | 170/4 | €2,349,422 | €2,796,980 | +€447,558 | +19.0% |
| Credit institutions | 173 | €2,349,422 | €2,796,980 | +€447,558 | +19.0% |
| Amounts payable within one year | 42/48 | €4,990,367 | €5,439,398 | +€449,031 | +9.0% |
| Current portion of amounts payable after more than one year | 42 | €452,675 | €558,692 | +€106,017 | +23.4% |
| Trade debts | 44 | €2,854,114 | €3,348,227 | +€494,113 | +17.3% |
| Suppliers | 440/4 | €2,798,667 | €3,267,294 | +€468,627 | +16.7% |
| Bills of exchange payable | 441 | €55,447 | €80,933 | +€25,486 | +46.0% |
| Taxes, remuneration and social security | 45 | €899,174 | €967,821 | +€68,647 | +7.6% |
| Taxes | 450/3 | €58,105 | €77,046 | +€18,941 | +32.6% |
| Remuneration and social security | 454/9 | €841,069 | €890,775 | +€49,706 | +5.9% |
| Other amounts payable | 47/48 | €784,404 | €564,658 | -€219,746 | -28.0% |
| Accrued charges and deferred income | 492/3 | €332,181 | €205,836 | -€126,345 | -38.0% |
| Operating income | 70/76A | €49,086,952 | €52,011,175 | +€2.9m | +6.0% |
| Turnover | 70 | €48,669,482 | €51,540,092 | +€2.9m | +5.9% |
| Other operating income | 74 | €399,834 | €443,436 | +€43,602 | +10.9% |
| Non-recurring operating income | 76A | €17,636 | €27,647 | +€10,011 | +56.8% |
| Operating charges | 60/66A | €47,047,336 | €49,718,527 | +€2.7m | +5.7% |
| Goods for resale, raw materials and consumables | 60 | €31,822,056 | €33,518,451 | +€1.7m | +5.3% |
| Purchases | 600/8 | €32,552,404 | €33,932,049 | +€1.4m | +4.2% |
| Change in stocks: decrease (increase) | 609 | -€730,348 | -€413,598 | +€316,750 | +43.4% |
| Services and other goods | 61 | €6,769,070 | €7,142,276 | +€373,206 | +5.5% |
| Remuneration, social security and pensions | 62 | €7,690,177 | €8,014,824 | +€324,647 | +4.2% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €680,664 | €773,570 | +€92,906 | +13.6% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | -€49,411 | - | +€49,411 | |
| Provisions for liabilities and charges: additions (uses and reversals) | 635/8 | €31,100 | - | -€31,100 | |
| Other operating charges | 640/8 | €103,680 | €269,406 | +€165,726 | +159.8% |
| Operating profit (loss) | 9901 | €2,039,616 | €2,292,648 | +€253,032 | +12.4% |
| Financial income | 75/76B | €632,602 | €620,923 | -€11,679 | -1.8% |
| Recurring financial income | 75 | €632,602 | €620,923 | -€11,679 | -1.8% |
| Other financial income | 752/9 | €632,602 | €620,923 | -€11,679 | -1.8% |
| Financial charges | 65/66B | €121,393 | €114,141 | -€7,252 | -6.0% |
| Recurring financial charges | 65 | €95,326 | €109,131 | +€13,805 | +14.5% |
| Debt charges | 650 | €72,953 | €83,866 | +€10,913 | +15.0% |
| Other financial charges | 652/9 | €22,373 | €25,265 | +€2,892 | +12.9% |
| Non-recurring financial charges | 66B | €26,067 | €5,010 | -€21,057 | -80.8% |
| Profit (loss) for the period before taxes | 9903 | €2,550,825 | €2,799,430 | +€248,605 | +9.7% |
| Income taxes | 67/77 | €694,742 | €762,951 | +€68,209 | +9.8% |
| Taxes | 670/3 | €694,742 | €762,951 | +€68,209 | +9.8% |
| Profit (loss) for the period | 9904 | €1,856,083 | €2,036,479 | +€180,396 | +9.7% |
| Profit (loss) for the period to be appropriated | 9905 | €1,856,083 | €2,036,479 | +€180,396 | +9.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.